In murine models of HNSCC, TIM-3 expression is upregulated in response to PD-1 inhibition, driven by the activation of the PI3K/AKT/mTOR pathway via cross-talk between PD-1 and TIM-3 [190,191]. This evidence concerns the gene PDCD1 and head and neck squamous cell carcinoma.